1. Home
  2. SYRE vs ITGR Comparison

SYRE vs ITGR Comparison

Compare SYRE & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.03

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Integer Holdings Corporation

ITGR

Integer Holdings Corporation

HOLD

Current Price

$78.83

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
ITGR
Founded
2013
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2016
2000

Fundamental Metrics

Financial Performance
Metric
SYRE
ITGR
Price
$33.03
$78.83
Analyst Decision
Strong Buy
Buy
Analyst Count
6
8
Target Price
$56.50
$95.00
AVG Volume (30 Days)
925.8K
638.6K
Earning Date
11-04-2025
10-23-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.42
Revenue
N/A
$1,831,074,000.00
Revenue This Year
N/A
$9.58
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$32.07
Revenue Growth
N/A
9.54
52 Week Low
$10.91
$62.00
52 Week High
$35.31
$146.36

Technical Indicators

Market Signals
Indicator
SYRE
ITGR
Relative Strength Index (RSI) 62.10 63.89
Support Level $32.50 $77.30
Resistance Level $34.84 $80.69
Average True Range (ATR) 1.48 2.09
MACD -0.37 1.17
Stochastic Oscillator 25.90 81.07

Price Performance

Historical Comparison
SYRE
ITGR

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Share on Social Networks: